How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Protein G, L, And A Resin Market
- By Resin Type: Protein A Resin, Protein G Resin, Protein L Resin, Protein A/G Resin
- By Form Factor: Pre-packed Columns, Bulk Resin, Spin Columns, Magnetic Beads
- By Application: Monoclonal Antibody Purification, Polyclonal Antibody Purification, Fc Fusion Protein Purification, Immunoglobulin Purification, Diagnostic Assays
- By End-User: Biopharmaceutical Companies, Research Laboratories, Diagnostic Companies, Contract Manufacturing Organizations (CMOs), Academic Institutions
- By Binding Capacity: High Capacity Resins, Medium Capacity Resins, Low Capacity Resins
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Protein A Resin leads By Resin Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Protein G, L, And A Resin Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Resin Type 4
Form Factor 4
Application 5
End-User 5
Binding Capacity 3
Companies profiled
Cytiva (formerly GE Healthcare Life Sciences)
Thermo Fisher Scientific
Sartorius AG
Merck KGaA (MilliporeSigma)
Bio-Rad Laboratories
Repligen Corporation
Pall Corporation (a Danaher company)
Agilent Technologies
Tosoh Bioscience
BioVision Inc.
Sinobiological Inc.
GenScript Biotech Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cytiva (formerly GE Healthcare Life Sciences)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Repligen Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Pall Corporation (a Danaher company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Agilent Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tosoh Bioscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioVision Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Sinobiological Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →GenScript Biotech Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Abcam plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Rockland Immunochemicals Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Creative Biolabs
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,548M by 2033 · 3.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Protein A Resin46.2
- Protein G Resin19.3
- Protein L Resin23.0
- Protein A/G Resin11.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,633M → $2,300M · 4.4%
Europe$1,138M → $1,670M · 4.9%
Asia Pacific$1,039M → $1,288M · 2.7%
Latin America$643.2M → $820.0M · 3.1%
Middle East and Africa$494.8M → $709.7M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.522026
3.532027
3.532028
3.552029
3.562030
3.582031
3.602032
3.602033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cytiva (formerly GE Healthcare Life Sciences)12.9
- Thermo Fisher Scientific16.2
- Sartorius AG12.7
- Merck KGaA (MilliporeSigma)12.8
- Bio-Rad Laboratories7.9
- Repligen Corporation9.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Resin Type24.4%
Form Factor13.2%
Application16.8%
End-User27.2%
Binding Capacity18.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.9
- Europe24.6
- Asia Pacific19.0
- Latin America12.1
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cytiva (formerly GE Healthcare Life Sciences) | 95 | 81 | 78 | 80 | 94 | 82 | 85 |
| Thermo Fisher Scientific | 93 | 87 | 93 | 71 | 80 | 93 | 86 |
| Sartorius AG | 68 | 81 | 68 | 67 | 77 | 67 | 71 |
| Merck KGaA (MilliporeSigma) | 58 | 66 | 62 | 82 | 77 | 65 | 68 |
| Bio-Rad Laboratories | 63 | 62 | 55 | 65 | 55 | 63 | 61 |
| Repligen Corporation | 57 | 49 | 69 | 66 | 50 | 62 | 59 |
| Pall Corporation (a Danaher company) | 62 | 56 | 64 | 52 | 41 | 56 | 55 |
| Agilent Technologies | 37 | 48 | 41 | 36 | 39 | 49 | 42 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cytiva (formerly GE Healthcare Life Sciences)
- Thermo Fisher Scientific
- Sartorius AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cytiva (formerly GE Healthcare Life Sciences) | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | − | ✓ | ✓ |
| Sartorius AG | ◐ | ✓ | ◐ | ◐ | ◐ | − |
| Merck KGaA (MilliporeSigma) | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Bio-Rad Laboratories | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Repligen Corporation | ◐ | − | ✓ | ◐ | − | − |
| Pall Corporation (a Danaher company) | ◐ | ◐ | ◐ | − | − | − |
| Agilent Technologies | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific86
2Cytiva (formerly GE Healthcare Life Sciences)85
3Sartorius AG71
4Merck KGaA (MilliporeSigma)68
5Bio-Rad Laboratories61
6Repligen Corporation59
7Pall Corporation (a Danaher company)55
8Agilent Technologies42
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Cytiva (formerly GE Healthcare Life Sciences)Thermo Fisher Scientific
Challenger2
Strong scale, closing on the leaders.
Sartorius AGMerck KGaA (MilliporeSigma)
Contender2
Focused players with pockets of strength.
Bio-Rad LaboratoriesRepligen Corporation
Niche2
Specialists in a single segment or region.
Pall Corporation (a Danaher company)Agilent Technologies
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Resin Type in North America, then scale across Protein G, L, And A Resin Market — a $91M beachhead inside a $1.79B market.
Beachhead (SOM)$91Mobtainable near-term
Serviceable (SAM)$633Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Protein A Resin
Best fit — highest urgency & budget in Resin Type.
Economic buyer75 fit
Protein G Resin
Strong fit — clear ROI and a fast path to value.
End user67 fit
Protein L Resin
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Resin Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form Factor & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel25%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Resin Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Protein G, L, And A Resin Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified22%
Evaluation13%
Closed-won5%
$15.7KCAC
$62KLTV
4.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Protein G, L, And A Resin Market is a durable-growth opportunity — $4.92B by 2033, compounding at 9.8%.
TAM · 2025$2.33Btoday
TAM · 2033$4.92Bforecast
CAGR9.8%2027–2033
Cumulative$31.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.92BTotal addressable market
SAM$1.88BServiceable available market
SOM$407MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Resin Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Resin Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.92BLarge & growingTAM by 2033 at 9.8% CAGR
$1.88BServiceable nowreachable with today’s model
$407MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.84BBear6.4% CAGR
$4.92BBase9.8% CAGR
$6.30BBull13.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form Factor optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Protein G, L, And A Resin Market — a $9.89B market by 2033. Plan: grow share from 5.8% to 12.2%.
Market size · 2033$9.89Btotal addressable
Market CAGR10.9%2027–2033
Target share12.2%from 5.8% today
Revenue ambition$1.21Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.8% | 12.2% | On track |
| Revenue | $555M | $1.21B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.6% | 40.4% | On track |
| Customer retention | 89.8% | 96.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Resin Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form Factor capability
A defensible second engine — invest in Form Factor to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Resin Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form Factor
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $169M capacity & capability investment
- Greenlight bolt-on M&A in Form Factor
- Authorise North America expansion plan
- Fund R&D program for Resin Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Protein G, L, And A Resin Market conversation — a $7.09B market you can size, segment and defend in minutes.
Market size · 2033$7.09Btotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers965+accounts in scope
Typical ROI5.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Resin Type
Goal Grow share in Resin Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.9×return on cost, year one
< 3 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Cytiva (formerly GE Healthcare Life Sciences)Thermo Fisher ScientificSartorius AGMerck KGaA (MilliporeSigma)Bio-Rad LaboratoriesRepligen CorporationPall Corporation (a Danaher company)Agilent Technologies+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Protein G, L, And A Resin Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Protein G, L, And A Resin Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Protein Gel Stain Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportProtein Gel Macromolecular Imagers Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportProtein Free Medium Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportProtein-free CHO Media Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportProtein Free Blocking Buffer Market
Market size, share, segmentation and regional forecast.
$975M market · 2025 base year
View reportProtein-free and Serum-free Media Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportProtein Extraction Used HEPES Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportProtein Extraction Kit Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportProtein Expression Vector Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportProtein Expression and Purification Technology Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportProtein Expression and Purification Services Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportProtein Engineering Service Market
Market size, share, segmentation and regional forecast.
$895M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.